Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
Lindsay N. Donald, DABT, Vice President, Pharmaceuticals and Healthcare
Lindsay N. Donald has over 35 years of experience drug development experience in within pharmaceutical, biotechnology companies and contract research organizations. He has been an American Board Certified Toxicologist for over 25 years and has worked in a variety of therapeutic areas including anti-inflammatory, anti-infective, oncology, gastro-intestinal disorders and numerous biological products such as thrombolytics, cytokines, monoclonal antibodies and growth factors.
As Vice President of the Pharmaceutical & Healthcare Group at Intertek Scientific & Regulatory Consultancy (formerly Cantox), Lindsay N. Donald is intimately involved with the strategic planning, design and implementation of drug development programs for clients. Nonclinical and clinical safety data in support of regulatory filings are critically evaluated and he represents clients with various international regulatory agencies including the Food & Drug Administration and Health Canada.
Need help or have a question?